Prostate Cancer
12 videos · last 6 months shuffled daily, then older videos newest first
▶
36:39 Clinical Trials: Prostate Cancer + New Nuclear Medicines
Katie Clift talks to Simone Leyden AM of Telix Pharmaceuticals about how clinical trials are shaping nuclear medicine for prostate cancer, and why patient participation in research matters.
▶
3:35 Oncology Bytes: Dr Piyush Aggarwal on the Lu-PRIME Phase II Trial
Dr Piyush Aggarwal of PGIMER Chandigarh presents preliminary results from Lu-PRIME, a Phase II trial of 177Lu-PSMA-617 primed with enzalutamide in 20 men with metastatic castration-resistant prostate cancer.
▶
3:17 RTOG 9601 Trial Post RP
Dr. Daniel Spratt, then a radiation oncologist at the University of Michigan, on the Decipher Prostate genomic classifier and the RTOG 9601 trial after radical prostatectomy.
▶
18:54 OTEOB From ASCO 2026: What’s Changing in Prostate, Lung and Multiple Myeloma Research
Monty Pal, M.D., talks with Alan Bryce, M.D., Kristin Higgins, M.D., and Joseph Mikhael, M.D., of City of Hope about the prostate, lung and multiple myeloma research shaping conversations at ASCO 2026.
▶
1:19 Perioperative Apalutamide in High-Risk Localized Prostate Cancer (PROTEUS)
NEJM Group summarises the phase 3 PROTEUS trial, in which ADT plus apalutamide in high-risk localized prostate cancer produced more pathological complete response or minimal residual disease and 5-year metastasis-free survival than ADT plus placebo.
▶
39:29 ASCO 2026: Highlights and Analysis
Associate Professor Bishal Gyawali talks to ecancer about ASCO 2026 presentations across GI, pancreatic, lung, breast and prostate cancer, including daraxonrasib in metastatic pancreatic adenocarcinoma.
▶
40:08 Upcoming Clinical Trials in Metastatic Prostate Cancer
Dr. Connor Wells, a medical oncologist at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary, discusses new clinical trials and treatments for metastatic prostate cancer in a Prostate Cancer Foundation Canada seminar.
▶
14:53 Finding and Choosing Prostate Cancer Clinical Trials
The Prostate Cancer Research Institute explains clinical trial phases, placebos and eligibility criteria, and how patients can find a prostate cancer trial and a physician to help them take part.
▶
29:22 Radiotheranostics in Prostate Cancer: Dr. Johannes Czernin
Dr. Johannes Czernin reviews the prostate cancer trials behind FDA approvals of radiotheranostics, ongoing phase 3 trials that would move them earlier in treatment, and supply, access and the business case.
▶
7:48 Focus RT Prostate Cancer Trial: Participant FAQs
The National Cancer Institute answers prospective participants' questions about the Center for Cancer Research's Focus RT prostate cancer trial (NCT05616650), led by Krishnan R. Patel, M.D., of the Radiation Oncology Branch.
▶
20:53 The Future of Targeted Radiopharmaceutical Therapy in Prostate Cancer
Katie Clift hosts a session on the ProstACT GLOBAL study, how TLX591 differs from existing treatments, and recruitment across 12 Telix trial sites in Australia and New Zealand.
▶
16:23 Ongoing Clinical Trials in Prostate Cancer
Daniel P. Petrylak, MD, of Yale University Cancer Center, reviews prostate cancer trials including talazoparib and lutetium PSMA, T-cell engagers JANX007 and AMG 509, and the NCI MATCH and PREDICT trials, for Grand Rounds in Urology.